Corporate News     03-Nov-23
Himadri Speciality Chemical allots 6.72 lakh equity shares on conversion of warrants
Himadri Speciality Chemical has allotted 6,72,000 equity shares on conversion of equal number of warrants on 03 November 2023. Consequently, the paid up equity share capital has increased to Rs. 44,06,94,573/-consisting of 44,06,94,573 equity shares of Re. 1/- each.
Previous News
  Himadri Speciality Chemical revises AGM date
 ( Corporate News - 18-Nov-20   12:52 )
  Himadri Speciality Chemical allots 62.15 lakh equity shares
 ( Corporate News - 17-Jun-23   16:28 )
  Himadri Speciality Chemical to conduct board meeting
 ( Corporate News - 23-Jun-21   14:33 )
  Himadri Speciality Chemical AGM scheduled
 ( Corporate News - 24-Aug-21   16:46 )
  Stocks continue trading with losses; telecom shares slide
 ( Market Commentary - Mid-Session 12-Jun-19   14:27 )
  Himadri Speciality Chemical standalone net profit rises 20.26% in the December 2018 quarter
 ( Results - Announcements 29-Jan-19   17:13 )
  Himadri Speciality Chemical gets revision in credit ratings
 ( Corporate News - 14-Jul-17   16:48 )
  Himadri Speciality Chemical to table results
 ( Corporate News - 12-Jul-23   10:28 )
  Himadri Speciality Chemical standalone net profit declines 79.66% in the December 2019 quarter
 ( Results - Announcements 14-Feb-20   08:31 )
  Himadri allots equity shares pursuant to option plan
 ( Corporate News - 23-Oct-19   15:59 )
  Himadri Specialty rises as Q4 PAT climbs 51% YoY
 ( Hot Pursuit - 26-Apr-24   10:39 )
Other Stories
  LMW schedules board meeting
  03-Jul-25   09:15
  Julien Agro Infratech announces board meeting date
  03-Jul-25   09:15
  Alembic Pharmaceuticals announces acquisition of Utility Therapeutics
  03-Jul-25   09:15
  Shriram Asset Mgt. Company schedules AGM
  03-Jul-25   09:14
  Ideaforge Technology to convene AGM
  03-Jul-25   09:14
  D-Link (India) to announce Quarterly Result
  03-Jul-25   09:14
  Tuni Textile Mills to conduct board meeting
  03-Jul-25   09:14
  Biocon Biologics receives EU marketing authorisation for Vevzuo® and Evfraxy® biosimilars of Denosumab
  03-Jul-25   09:12
  Shakti Pumps launches QIP issue
  03-Jul-25   09:08
  Jai Mata Glass to conduct board meeting
  02-Jul-25   19:12
Back Top